We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Messe Düsseldorf Promotes International “MEDICAlliance” Portfolio at ADLM 2024

By LabMedica International staff writers
Posted on 31 Jul 2024

Messe Düsseldorf (Düsseldorf, Germany) is participating in the ADLM Clinical Lab Expo 2024 to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe. More...

At ADLM booth 4421, visitor and exhibitor information are available for MEDICA 2024, World Forum for Medicine, and COMPAMED 2024, high-tech solutions for medical technology (held currently from November 11 – 14, 2024 in Düsseldorf, Germany), Medical Fair China (August 2024 in Suzhou), Medical Fair Asia and Medical Manufacturing Asia (held concurrently in September 2024 in Singapore) as well as Medical Fair Thailand (September 2025 in Bangkok) and Medical Fair India (2025 in New Delhi).

With over 5,300 exhibitors from almost 70 countries and 83,000 visitors from around the globe, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. The event presents a wide range of innovative products and services from the fields of medical imaging, laboratory technology, diagnostics, health IT, and mobile health as well as physiotherapy/orthopedic technology and medical consumables. The exhibitors showcase innovations along the industry's entire value chain and for the complete workflow of modern healthcare. The extensive program of forums, conferences, and special shows complement the exhibits. On average, 800+ international IVD companies and lab equipment manufacturers have participated each year, displaying the latest global advancements in laboratory medicine, equipment, and molecular diagnostic solutions.

Related Links:
Messe Düsseldorf


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
Creatine Kinase-MB Assay
CK-MB Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.